These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7793299)

  • 1. Insulin secretion in obese and non-obese women with polycystic ovary syndrome and its relationship with hyperandrogenism.
    dos Reis RM; Foss MC; de Moura MD; Ferriani RA; Silva de Sá MF
    Gynecol Endocrinol; 1995 Mar; 9(1):45-50. PubMed ID: 7793299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
    Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
    Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T; Finegood DT; Fantus IG; Morris D
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
    Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma androgens and oestradiol during oral glucose tolerance test in patients with polycystic ovaries.
    Tiitinen A; Pekonen F; Stenman UH; Laatikainen T
    Hum Reprod; 1990 Apr; 5(3):242-5. PubMed ID: 2191000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.
    Anttila L; Koskinen P; Jaatinen TA; Erkkola R; Irjala K; Ruutiainen K
    Hum Reprod; 1993 Aug; 8(8):1179-83. PubMed ID: 8408513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
    Dunaif A; Segal KR; Futterweit W; Dobrjansky A
    Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
    Lanzone A; Fulghesu AM; Pappalardo S; Proto C; Le Donne M; Andreani CL; Muscatello R; Caruso A; Mancuso S
    Gynecol Obstet Invest; 1990; 29(2):149-53. PubMed ID: 2110544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J; Bergh T; Berne C; Wide L; Lithell H
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2586-93. PubMed ID: 7673399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of plasma insulin levels in obese and non-obese women with functional hyperandrogenism.
    Sütterlin M; Steck T
    Gynecol Endocrinol; 1995 Mar; 9(1):37-44. PubMed ID: 7793298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women.
    Fox JH; Licholai T; Green G; Dunaif A
    Fertil Steril; 1993 Dec; 60(6):994-1000. PubMed ID: 8243706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.